To include your compound in the COVID-19 Resource Center, submit it here.

Aptalis Holdings, Forest Laboratories deal

Forest will acquire gastrointestinal company Aptalis for $2.9 billion in cash.

Read the full 119 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE